← Back to all trials
Not Yet Recruiting
NCT05752318
Analysis of the Persistence, Reservoir and HIV Latency
Conditions: HIV Infected Individuals, Informed Consent
Sex: All
Ages: 18 Years – N/A
Enrollment: 500
Sponsor: University Hospital, Strasbourg, France
Summary
The APRIL study aims at analyzing HIV reservoirs, latency and persistence on antiretroviral therapy.
It enrolls HIV-infected adults providing blood samples of which peripheral blood mononuclear cells are stored.
The frequency, phenotype and inducibility of HIV-infected cells are then analyzed.
These parameters may vary across the different clinical and therapeutic settings.
Eligibility Criteria
Inclusion Criteria:HIV-infectionAdults (>18 years)Social insuranceInformed consentExclusion Criteria:HIV-uninfected<18 yearsLack of social insuranceLack or withdraw of consent
Source: ClinicalTrials.gov (NCT05752318). StuddyBuddy aggregates publicly available trial information.
